Dermatology experts examine the role of IL-17 inhibitors in psoriasis management, focusing on treatment strategies, swift clinical responses, and their effectiveness across various anatomical sites affected by plaque psoriasis.
Study Compares Dose Escalation with Biologics in Psoriasis
The Cutaneous Connection: An Inside Look of the Inclusive Atlas
Oral Zasocitinib Demonstrates Safety and Efficacy in Moderate to Severe Plaque Psoriasis
The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics
Patients With Psoriasis Demonstrate Higher Rates of Helicobacter Pylori Infection Versus Controls
Higher Risankizumab Adherence with New Injection Device